CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 96 enrolled
Drug / intervention
Bupivicaine 0.5% +2 moredrug
Likely dose
Bupivacaine 0.5% via continuous infusion regional anesthetic catheter (Breg Pain Care 3000)AI-extracted
Key inclusion· 5
  • ✓Daily pain that restricts work, recreation, and/or activities of daily living
  • ✓ASA risk class 1 or 2
  • ✓Age 15-65 years (parental consent required for subjects under 18)
  • ✓Cognitive function sufficient to understand protocol and complete study assessments
Key exclusion· 11
  • ✕Neuropathic joint
  • ✕Remote source of ongoing sepsis
  • ✕Severe vascular disease
  • ✕Known allergy or sensitivity to amide-type local anesthetics, acetaminophen, or opioids

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00178178
NCT00178178N/ACompleted
CompareCT.gov

A Placebo Controlled, Prospective, Randomized Clinical Investigation of the Efficacy of Continuous Infusion Regional Anesthetic on Postoperative Pain Following Arthroscopic Anterior Cruciate Ligament Reconstruction: A Comparison of Three Catheter Placement Positions

University of Rochester·interventional·Posted Sep 15, 2005·Updated Sep 11, 2015

In Brief

A clinical study evaluating Breg Pain Care 3000 Catheter, Bupivicaine 0.5%, and 1 other intervention for Pain, Postoperative. Completed, enrolled 96 participants across 1 site.

Detailed Summary

This investigation will evaluate the subjective effect on postoperative pain of three catheter placements in the knee: 1. intraarticular infusion only, 2. patellar tendon harvest site only, 3. both intraarticular and patellar tendon harvest site.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesUnited States
CollaboratorsBREG, Inc

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 15, 2005
Enrollment StartMar 1, 2005
Primary CompletionNov 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 20.8 years ago

Interventions

Breg Pain Care 3000 Catheterdevice

Device: Breg Pain Care 3000 Catheter

Bupivicaine 0.5%drug

Drug: Bupivicaine 0.5 %

Placebodrug

Drug: Placebo